IGF2BP2/3. In clear cell renal cell carcinoma, IGF2BP3 promotes extracellular matrix (ECM) deposition, including COL6A1, LAMA5, and FN1, by stabilizing their m6A-methylated transcripts [61]. This evidence concerns the gene COL6A1 and clear cell renal carcinoma.